Press: Quit Genius partners with Evernorth, a Cigna Corporation, to provide broader access to digital addiction solution as addiction numbers soar during COVID-19

Based on decades of scientific research & supported by ongoing clinical studies

Quit Genius has been validated in a randomized-controlled trial and 6 peer-reviewed studies and counting.

With independent research published in leading peer-reviewed journals, the numbers speak for themselves.

60k
people have successfully quit smoking using Quit Genius
52%
biochemically-verified quit rate at 28 days
74%
of cigarettes’ reduced by users who continued to smoke

Outcomes in a 530 participant randomized controlled trial

Our single-blinded randomized controlled trial compared Quit Genius against Usual Care in 530 participants. Carbon Monoxide verified outcomes demonstrated a 52% quit rate in the Quit Genius versus 32% in the Usual Care arm at 28 days post quit date.

READ THE PAPER

Quit Genius is consistently rated as the leading digital program for effective behavior change across multiple peer-reviewed papers.

2020

Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial

Webb et al. / JMIR Mental Health

View paper
2019

Using Health and Well-Being Apps for Behavior Change: A Systematic Search and Rating of Apps

McKay et al. / JMIR Mhealth Uhealth

View paper
2019

Use of Gamification Strategies and Tactics in Mobile Applications for Smoking Cessation: A Review of the UK Mobile App Market

Rajani et al. / BMJ Open

View paper
2018

Evaluating Mobile Phone Applications for Health Behaviour Change: A Systematic Review

McKay et al. / J Telemed Telecare

View paper
2018

Effective Behavioral Changes through a Digital mHealth App

Lin et al. / JMIR Mhealth Uhealth

View paper
2018

Evaluation of Two Mobile Health Apps in the Context of Smoking Cessation

Tudor-Sfetea et al. / JMIR Mhealth

View paper
2016

Game On? Smoking Cessation Through the Gamification of mHealth: A Longitudinal Qualitative Study

El-Hilly et al. / JMIR Serious Games

View paper

Ongoing research

Quit Genius breaks the shell with an evidence-based program designed to engage and set each member up for a successful quit attempt.

Single-blinded Randomized Controlled Trial

The purpose of this randomised clinical trial is to compare the effectiveness of the Quit Genius app to “very brief advice” on quitting smoking. As well as smoking abstinence, the study will also look at the quality of life, self-efficacy and wellbeing of Quit Genius users.

Academic collaborators:

Self-efficacy and motivation for smoking cessation in the context of a digital health application

In collaboration with researchers at Imperial College London the purpose of this study is to investigate the impact of Quit Genius on the self-efficacy and motivation of smokers wanting to quit. Cessation outcomes and app-engagement will also be assessed.

Academic collaborators:

Partner with us

We are always excited to work with academic institutions and collaborators who want to make an impact on smoking cessation and behavioural healthcare. If this sounds like you, get in touch with us here.
Get a demo